HIGHLIGHTS
- who: Lipid bilayer disks and collaborators from the Department of Immunology, Genetics and Pathology, Uppsala University, , Uppsala have published the article: Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks, in the Journal: Nanomaterials 2020, x of /2020/
- what: The authors demonstrate that VIP116 can be stably formulated in lipodisks (maximum peptide/lipid molar ratio 0.11). The authors have present study, the authors investigated the feasibility of delivering the novel p53-activating peptide VIP116 to developed and utilized EGFR-targeted lipodisks for delivery of different classes of anti-cancer drugs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.